Please Subscribe to get a daily link to Pat's blog via email


Your privacy is important to us. We will never spam you and keep your personal data secure.

Dr. Rajkumar

Home/Tag:Dr. Rajkumar
9 06, 2015

Dr. Rajkumar shares list of most important ASCO trials

Tags: , , , |7 Comments

Renowned Tweeter, Cindy from New Jersey, @Myeloma Teacher, passed along Dr. Vincent Rajkumar's Top Seven myeloma-related abstracts from this year's American Society of Clinical Oncology annual meetings in Chicago: Top 7 #ASCO15 #Myeloma Abstracts - @VincentRK 7- Panorama - tml 6- Elo- Vd vs Vd - tml 5- CHAMPION - 4-CALGB Len

20 11, 2014

Listin to brodcasts featuring myeloma’s best: Dr. Gareth Morgan (UAMS) and Dr Vincent Rajkumar Mayo Clinic

Tags: , , , , |0 Comments

Sorry for the delay.  Cure Talks (new name, updated site) has been under construction.  Click on the link below: Then drop down under first large graphic and click on the "go" arrow on the right side to listen.  It's worth the trouble! Cure Talks Director, Priya Menon, promises access will be easier next time. 

14 08, 2013

Well known myeloma specialist: Patients who don’t achieve CR may live as long as patients who do

Tags: , , , |36 Comments

Last Saturday the Myeloma Beacon ran an opinion piece by one of the best and brightest multiple myeloma specialists, Mayo Clinic's Dr. Vincent Rajkumar,  titled, Should Myeloma Patients Panic If They Do Not Achieve A Complete Response? In it, Dr. Rajkumar stressed that myeloma patients should not despair if they are unable to achieve a

6 03, 2013

Mayo Clinic’s Dr. S. Vincent Rajkumar: Doctors and patients should be cautious when using curcumin

Tags: , , , |6 Comments

Myeloma patients in the know recognize curcumin, an extract of the spice turmeric, to be a potentially powerful anti-myeloma supplement.  But like most supplements, curcumin is unregulated and understudied.  Anecdotal evidence looks extremely promising.  So much so that activists (like me) in the myeloma community have endorsed it as a natural, inexpensive complementary medicine option

15 02, 2013

New study pinpoints Velcade as drug of choice for high risk myeloma patients

Tags: , , , , , , , , |11 Comments

Our good friend and nutritional columnist, Danny Parker, is excited about a new study released last week in the Journal of the American Society of Hematology:  Improving overall survival and overcoming adverse prognosis in the treatment of cytogenetically high-risk multiple myeloma. Danny is considered a high risk patient, so I understand why this comprehensive study

9 02, 2013

Everything you always wanted to know about POM but were afraid to ask…

Tags: , , , , , , , , , , , , |4 Comments

The internet is flooded with excitement following the FDA's limited approval of celgene's newest IMiD, pomalidomide (trade name, POMALYST).  POM is an analogue of thalidomide (trade name, Thalomid).  Researchers actually developed POM before Revlimid, but sat on it for a decade--choosing to intensify clinical study activity recently, culminating in yesterday's FDA approval. I'm going to

16 01, 2012

Monday morning homework

Tags: , , , , , , , |14 Comments

Last month I was featured in a Nature Magazine article about multiple myeloma and stem cell transplants: Stem cells: Transplants on trial By Elie Dolgin They included this handsome picture, too! Point of fact, the photo editors--located in England--flipped the captions of the two pictures I sent them.  The actual stem cell infusion pic was

10 12, 2011

Hello from San Diego! Full coverage of Friday evening’s IMF Satellite Symposium event (Part One)

Tags: , , , |0 Comments

Good morning!  Time zones.  Who knew going from Florida to California would be such an adjustment! The sun was setting as I flew in over downtown San Diego late yesterday afternoon,  I arrived  just in time to rush over to the convention center to cover last evening’s event, Myeloma Questions and Controversies:  New Developments in

18 04, 2011

Every Multiple Myeloma Patient Or Caregiver Should Read Friday’s Myeloma Beacon Feature About Emerging Myeloma Therapies

Tags: , , , , , , , , |2 Comments

The Myeloma Beacon ran an excellent review of new anti-myeloma therapies which are in late stages of development:  Promising New Drugs For Myeloma: Will The Future Come Soon Enough?The article is written by Dr. S. Vincent Rajkumar with Mayo Clinic.  I was going to reference it over the weekend, but forgot about it until I

4 12, 2010

Live Coverage From IMF’s Multiple Myeloma Expert Panel Discussion Friday, December 3rd from the annual American Society of Hematology Meetings

Tags: , , , , , , , , |0 Comments

Good evening from the Grand Ballroom at the Peabody Hotel in Orlando, Florida.  I'm covering the IMF’s ASH kick-off event, Key Myeloma Questions for 2010: Latest Developments int Diagnosis, Prognosis and Risk Assessment in Multiple Myeloma.This should be of special interest to a cyber friend of mine, Thomas from Germany. Thomas contacted me three or four